Earnings Feed
Start Free
Home/Filings/4/0001209191-03-029064
4//SEC Filing

PETRICCIANI JOHN 4

Accession 0001209191-03-029064

CIK 0001131907other
View on SEC.govCompany Profile

Filed

Nov 5, 7:00 PM ET

Accepted

Nov 6, 5:57 PM ET

Size

9.9 KB

Accession

0001209191-03-029064

Insider Transaction Report

Form 4
Period: 2003-11-04
CANCERVAX CORPCNVX
PETRICCIANI JOHN
Sr.VP, Medical & Regulatory
Transactions
  • Conversion

    Common Stock

    2003-11-04+19,763→ 53,853 total
  • Conversion

    Common Stock

    2003-11-04+9,825→ 63,678 total
  • Conversion

    Series A Preferred Stock

    2003-11-04−19,763→ 0 total
    Exercise: $10.12→ Common Stock (19,763 underlying)
  • Conversion

    Series C Preferred Stock

    2003-11-04−11,307→ 0 total
    Exercise: $8.84→ Common Stock (11,307 underlying)
  • Conversion

    Common Stock

    2003-11-04+11,307→ 74,985 total
  • Conversion

    Series B Preferred Stock

    2003-11-04−9,825→ 0 total
    Exercise: $9.68→ Common Stock (9,825 underlying)
Footnotes (2)
  • [F1]Not applicable to this transaction.
  • [F2]Immediately convertible.

Documents

1 file

Issuer

CANCERVAX CORP

CIK 0001131907

→
Entity typeother

Related Parties

1
  • filerCIK 0001265786

Filing Metadata

Form type
4
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 5:57 PM ET
Size
9.9 KB
View on SEC.gov